Clinical Trials Logo

Post-Traumatic Stress Disorder clinical trials

View clinical trials related to Post-Traumatic Stress Disorder.

Filter by:

NCT ID: NCT00494650 Completed - Clinical trials for Post-Traumatic Stress Disorder

Cognitive Behavioral Treatment for Post-Traumatic Stress Disorder in People With Additional Serious Mental Illnesses

Start date: April 2008
Phase: N/A
Study type: Interventional

This study will evaluate the effectiveness of tailored cognitive behavioral therapy in treating post-traumatic stress disorder in people with additional mental illnesses.

NCT ID: NCT00465608 Completed - Clinical trials for Post-Traumatic Stress Disorder

Propranolol in Post Traumatic Stress Disorder

Reductrauma
Start date: April 2007
Phase: Phase 2
Study type: Interventional

Problem and Objectives: There is currently no pharmacological treatment for curing post traumatic stress disorder (PTSD). The investigators will test whether propranolol when given immediately after trauma evocation is able to decrease the strength of the traumatic memory, and by extension, the severity of PTSD symptoms associated with that memory. Hypotheses: 1. The subjects will show a significant pre/post decrease in PTSD symptoms. 2. Those gains will be maintained at follow-up. Study Design: Open pharmacological trial. Method: On the first visit (V1), the subjects will describe their traumatic experience in writing and will receive the propranolol. A script describing this experience will be constructed to be used in the subsequent encounters to elicit the trauma memory. A week later (V2), before receiving the propranolol, subjects will be asked to read aloud their trauma script while imagining it as vividly as possible for 10 minutes. This weekly treatment will be repeated 6 times (from V1 to V6). A total of 6 doses of propranolol will be given. A self-report measure will be used to monitor improvement in PTSD symptomatology on the following visits: V1, V4, V6, V7 and V8 (3 month follow-up). Statistical Analyses: A repeated measure ANOVA (pre-test, post-test, and 3-month follow-up) using the PTSD symptom score will be conducted.. Three t-tests will be performed to examine simple effects. The alpha level will be set at p = .05 (two-tailed). Fisher's exact test will be used to examine whether Ss still meet the diagnostic criteria for PTSD at the end of the study. Clinical Implications: If this treatment is effective, a randomized controlled trial will be launched. This treatment has the potential to become the first pharmacological treatment designed to cure PTSD.

NCT ID: NCT00447538 Completed - Clinical trials for Post-Traumatic Stress Disorder

Posttraumatic Symptoms Among Toddlers and Their Parents Following Exposure to Terrorism

Start date: November 2005
Phase: Phase 4
Study type: Observational

The project utilize experience and knowledge gained from previous early childhood projects in NYC post 9/11 and Sderot. The overall goals are: 1. Identifying young children (under 6 years old) and their parents who are suffering from posttraumatic distress in the aftermath of the continuing conflict on Gaza border, Israel. 2. Increasing the capacity of local institutions to treat toddlers and families at risk. 3. Providing resilience -building services that strengthen the coping abilities of families and caregivers in response to continual terrorism.

NCT ID: NCT00417300 Completed - Clinical trials for Post-Traumatic Stress Disorder

Comparing Behavioral Therapies for Treating Adolescents With Post-Traumatic Stress Disorder Related to Sexual Abuse

Start date: February 2006
Phase: Phase 2
Study type: Interventional

This study will evaluate the comparative effectiveness of prolonged exposure therapy and client centered therapy in treating adolescents with post-traumatic stress disorder related to childhood sexual abuse or assault.

NCT ID: NCT00413296 Completed - Clinical trials for Post-Traumatic Stress Disorder

Levetiracetam in Post-Traumatic Stress Disorder

PTSD
Start date: November 2005
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to evaluate the short-term efficacy and safety of levetiracetam in post-traumatic stress disorder (PTSD) and to evaluate continuation effects of levetiracetam in preventing PTSD relapse. The hypothesis is that levetiracetam will be safe and effective in preventing relapse of PTSD.

NCT ID: NCT00353249 Completed - Clinical trials for Post-Traumatic Stress Disorder

Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder in Homeless Women

Start date: June 2008
Phase: Phase 1
Study type: Interventional

This study will determine the effectiveness of cognitive behavioral therapy in treating post-traumatic stress disorder in homeless women.

NCT ID: NCT00352469 Completed - Anxiety Disorders Clinical Trials

Trial of Seroquel SR for Alcohol Dependence and Comorbid Anxiety

Start date: February 2006
Phase: Phase 4
Study type: Interventional

Alcohol use disorders (AUDs) are a major problem facing our society. Their treatment is complex, and involves multiple behavioral and pharmacotherapy interventions. There are 3 approved medications for AUDs, but their efficacy for AUDs that co-exist with anxiety disorders is unknown. This study explores the effects of the medication, sustained-release quetiapine fumarate (Seroquel SR) for the treatment of alcohol dependence and co-morbid anxiety. Primary outcome measure is the amount of alcohol used. Secondary outcome measures include craving for alcohol, length of sobriety from drinking and level of anxiety with Seroquel SR.

NCT ID: NCT00348036 Completed - Depression Clinical Trials

Group Intervention for Interpersonal Trauma

Start date: September 2008
Phase: N/A
Study type: Interventional

This study will assess the acceptability and effectiveness of a six-session, modular, repeating group for low-income women who have symptoms of depression and/or post-traumatic stress disorder following interpersonal trauma exposure.

NCT ID: NCT00347269 Completed - Clinical trials for Post-traumatic Stress Disorder

Primary Care Intervention Strategy for Anxiety Disorders

Start date: June 2006
Phase: Phase 4
Study type: Interventional

This study will compare the effectiveness of an intervention strategy for the treatment of people with post traumatic stress disorder, generalized anxiety disorder, panic disorder, and social anxiety disorder in the primary care setting.

NCT ID: NCT00306540 Completed - Clinical trials for Post-Traumatic Stress Disorder

Use of Quetiapine as an Add on Therapy in the Treatment of Post Traumatic Stress Disorder

Start date: December 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate how effective quetiapine versus placebo is when added to an existing therapy, in reducing the symptoms of PTSD.